Funding · Company
Georgiamune, Inc.
Gaithersburg, MDBiotech & Pharma
Georgiamune, Inc. of Gaithersburg, MD has disclosed $93M across 1 Form D offering filed with the SEC on Aug 17, 2026.
$93M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$93M
Form D · Aug 17, 2026 ↗
Q3 2026
· target $132M
Filing details
HeadquartersGaithersburg, MDIndustryBiotech & Pharma (Biotechnology)SEC CIK0002148230Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →